Below, we explore how indication expansion is unfolding and what it means for clinical development in 2026 and beyond in obesity, oncology and cell and gene therapy
not trial-validated Endpoint Skin density (instrument-measured) Topical timeline 12 weeks Injectable framing Anecdotal
TrimRx provides access to GLP-1 receptor agonist medications (semaglutide, tirzepatide) through a fully online process: health questionnaire licensed provider review personalized prescription free home delivery unlimited telehealth check-ins
reduced nausea incidence (~15 % versus first-generation GLP-1s) is a key patient motivator
Crupi R, Impellizzeri D, Cuzzocrea S
But Serenas revelation signals a potential cultural shift - are we moving into an era where science, and not sweat alone, drives results